Evidence map›Paper›PMID 34911942›Full record

ArticleNature communications2021

Oxicam-type non-steroidal anti-inflammatory drugs inhibit NPR1-mediated salicylic acid pathway.

Nobuaki Ishihama, Seung-Won Choi, Yoshiteru Noutoshi, Ivana Saska, Shuta Asai, Kaori Takizawa, Sheng Yang He, Hiroyuki Osada, Ken Shirasu

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Establishment of a TRV-VIGS system in Coix (Frontiers in plant science · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Oxicam-type nonsteroidal anti-inflammatory drugs enhancePlant biotechnology (Tokyo, Japan) · 2022
    Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Nobuaki IshihamaPlant Immunity Research Group, RIKEN Center for Sustainable Resource Science, Yokohama, 230-0045, Japan.
Seung-Won ChoiPlant Immunity Research Group, RIKEN Center for Sustainable Resource Science, Yokohama, 230-0045, Japan.
Yoshiteru NoutoshiGraduate School of Environmental and Life Science, Okayama University, Okayama, 700-8530, Japan.ORCID http://orcid.org/0000-0001-8140-3722
Ivana SaskaPlant Immunity Research Group, RIKEN Center for Sustainable Resource Science, Yokohama, 230-0045, Japan.
Shuta AsaiPlant Immunity Research Group, RIKEN Center for Sustainable Resource Science, Yokohama, 230-0045, Japan.ORCID http://orcid.org/0000-0003-1898-1786
Kaori TakizawaPlant Immunity Research Group, RIKEN Center for Sustainable Resource Science, Yokohama, 230-0045, Japan.
Sheng Yang HeDepartment of Energy Plant Research Laboratory, Michigan State University, East Lansing, MI, 48824, USA.
Hiroyuki OsadaChemical Biology Research Group, RIKEN Center for Sustainable Resource Science, Wako, 351-0198, Japan.ORCID http://orcid.org/0000-0002-3606-4925
Ken ShirasuPlant Immunity Research Group, RIKEN Center for Sustainable Resource Science, Yokohama, 230-0045, Japan. ken.shirasu@riken.jp.ORCID http://orcid.org/0000-0002-0349-3870
RIKEN Center for Sustainable Resource Science · JPHoward Hughes Medical Institute · USOkayama University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nonsteroidal anti-inflammatory drugs (NSAIDs), including salicylic acid (SA), target mammalian cyclooxygenases. In plants, SA is a defense hormone that regulates NON-EXPRESSOR OF PATHOGENESIS RELATED GENES 1 (NPR1), the master transcriptional regulator of immunity-related genes. We identify that the oxicam-type NSAIDs tenoxicam (TNX), meloxicam, and piroxicam, but not other types of NSAIDs, exhibit an inhibitory effect on immunity to bacteria and SA-dependent plant immune response. TNX treatment decreases NPR1 levels, independently from the proposed SA receptors NPR3 and NPR4. Instead, TNX induces oxidation of cytosolic redox status, which is also affected by SA and regulates NPR1 homeostasis. A cysteine labeling assay reveals that cysteine residues in NPR1 can be oxidized in vitro, leading to disulfide-bridged oligomerization of NPR1, but not in vivo regardless of SA or TNX treatment. Therefore, this study indicates that oxicam inhibits NPR1-mediated SA signaling without affecting the redox status of NPR1.

Indexed as

Anti-Inflammatory Agents, Non-SteroidalArabidopsisArabidopsis ProteinsGene Expression Regulation, PlantMeloxicamPiroxicamSalicylic AcidAnti-Inflammatory Agents, Non-SteroidalArabidopsis ProteinsMeloxicamNPR1 protein, ArabidopsisNPR3 protein, ArabidopsisPiroxicamSalicylic Acidtenoxicam

Identifiers

PMID34911942
PMCPMC8674334
OpenAlexW4225789379

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.